1. Byulleten Natsyonalnogo kantser-reestra № 18 "Rak v Ukrayne, 2015-2016", Kyev, 2017. [Russian]
2. Quon H, Leong T, Haselow R, Leipzig B, Cooper J, Forastiere A. Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382). Int J Rad Oncol Bio Phys. 2011; 81 (3): 719-25. https://www.ncbi.nlm.nih.gov/pubmed/20888709. https://www.ncbi.nlm.nih.gov/pmc/articles/3612971. https://doi.org/10.1016/j.ijrobp.2010.06.038
3. Falli C, Bolner A, Gava A, et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs accelerate hyperfractionated radiotherapy vs concomitant radiotherapy and chemotherapy – a multicenter randomized trial. Radiotherapy and oncology. 2004; 73 (1): 676.
4. Garden AS, Pajak TF, Vokes E, et al. Preliminary results of RTOG 9703 – a phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinomas (SCC) of the head and neck. Proc of ASCO. 2001; 20: 223.
5. George L, Cozalet M, Digue L, et al. A dose volume histogram analysis of the PTV in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy. EJC. 2005; 3 (2): 1027.